SCHEMBL20097079

SCHEMBL20097079

CCc1cc2c(C)cccc2n1CC(=O)C(C)(C)CC

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 3/20 0.39
▸ F10 P00742 4/20 0.37
▸ POLB P06746 1/20 0.37
▸ MTNR1B P49286 1/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ ALDH1A1 P00352 3/20 0.36
▸ MEN1 O00255 2/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ HPGD P15428 1/20 0.36
▸ TDP1 Q9NUW8 2/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ TSHR P16473 2/20 0.35
▸ MAPK1 P28482 1/20 0.34
▸ SLC9A1 P19634 1/20 0.34
▸ CNR2 P34972 1/20 0.34
▸ HTT P42858 1/20 0.33
▸ F2 P00734 1/20 0.33
▸ TSPO P30536 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28815311 0.66 KDM4E (0.57) KDM4ERAB9AALDH1A1MEN1KMT2A
SCHEMBL27431550 0.66 PSEN1 (0.38) KDM4EF10POLBMTNR1BALDH1A1
SCHEMBL12110619 0.65 FABP4 (0.58) KDM4EALDH1A1HPGDTSPO
SCHEMBL699819 0.65 GPR35 (0.53) KDM4EF10POLBALDH1A1HPGD
SCHEMBL19644452 0.64 MAPT (0.45) KDM4EPOLBRAB9AALDH1A1MEN1
SCHEMBL27354976 0.64 TNF (0.51) KDM4EF10RAB9AMEN1KMT2A
SCHEMBL27343262 0.63 KDM4E (0.54) KDM4EPOLBALDH1A1L3MBTL1HTT
SCHEMBL19013560 0.62 NR1H2 (0.43) L3MBTL1SLC9A1
SCHEMBL10165552 0.62 HTR2A (0.51) KDM4ERAB9AALDH1A1MEN1KMT2A
SCHEMBL22978577 0.62 PLA2G10 (0.41) KDM4EF10POLBMTNR1BRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018073753-A1 FUSED TETRACYCLIC PYRIDONE COMPOUNDS AS ANTIVIRALS NOVARTIS AG (CH) 2018-04-26 — — WO disclosed
Send feedback